BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.370
-0.100 (-2.88%)
Jun 12, 2026, 4:00 PM EDT - Market closed
BioLineRx Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | - | -2.03 | -9.22 | -60.61 | -24.95 | -27.05 |
Depreciation & Amortization | 0.45 | 0.52 | 4.07 | 1.38 | 0.65 | 0.7 |
Stock-Based Compensation | 0.28 | 0.4 | 1.14 | 2.32 | 2.25 | 1.5 |
Other Adjustments | -1.06 | -8.23 | -18.03 | 19.1 | -5.43 | 1.82 |
Change in Receivables | 1.47 | 2.43 | -2.12 | -0.36 | - | - |
Changes in Inventories | 1.16 | 1 | -1.19 | -1.95 | - | - |
Changes in Accounts Payable | 0.97 | -3.48 | -5.51 | 5.51 | 1.89 | -0.56 |
Changes in Unearned Revenue | - | - | -12.96 | 12.96 | - | - |
Changes in Other Operating Activities | -1.31 | 1.31 | -0.04 | -0.96 | -0.65 | 0.02 |
Operating Cash Flow | -7.76 | -8.07 | -43.87 | -22.61 | -26.24 | -23.57 |
Capital Expenditures | -0.03 | -0.03 | -0.05 | -0.12 | -0.13 | -0.1 |
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - | - |
Purchases of Intangible Assets | - | -0 | -0 | -0.18 | -0.19 | - |
Purchases of Investments | -29.52 | -36.64 | -26.35 | -47.59 | -44 | -78 |
Proceeds from Sale of Investments | 31.89 | 28.13 | 55.78 | 49.33 | 48.32 | 39.87 |
Investing Cash Flow | 2.34 | -8.55 | 29.37 | 1.44 | 4.01 | -38.22 |
Long-Term Debt Issued | - | - | 19.22 | - | 9.13 | - |
Long-Term Debt Repaid | -4.5 | -4.5 | -14.43 | -1.54 | -2.83 | -3.38 |
Net Long-Term Debt Issued (Repaid) | -4.5 | -4.5 | 4.79 | -1.54 | 6.29 | -3.38 |
Issuance of Common Stock | 3.2 | 13.89 | 16.38 | 17.04 | 14.36 | 61.32 |
Net Common Stock Issued (Repurchased) | 3.2 | 13.89 | 16.38 | 17.04 | 14.36 | 61.32 |
Other Financing Activities | -0.45 | -0.51 | -0.51 | -0.45 | -0.22 | -0.2 |
Financing Cash Flow | -1.75 | 8.88 | 20.66 | 15.06 | 20.44 | 57.75 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.64 | 0.55 | 0.02 | -0.22 | -0.61 | 0.21 |
Net Cash Flow | -7.17 | -7.74 | 6.16 | -6.11 | -1.8 | -4.05 |
Free Cash Flow | -7.79 | -8.1 | -43.93 | -22.72 | -26.37 | -23.67 |
FCF Margin | -842.60% | -686.36% | -151.78% | -473.42% | - | - |
Free Cash Flow Per Share | -1.82 | -1.97 | -22.00 | -14.15 | -20.44 | -21.42 |
Levered Free Cash Flow | -4.87 | -7.2 | -20.12 | -45.33 | -16.9 | -30.36 |
Unlevered Free Cash Flow | -9.67 | -10.96 | -36.1 | -32.87 | -27.4 | -24.71 |